Press Releases

Research and Markets: Diabetes - Pipeline Review, H2 2012 Provides A Snapshot of the Global Therapeutic Scenario for Diabetes

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of Global Markets Direct's new report "Diabetes - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Diabetes - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetes. Diabetes - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


- A review of the Diabetes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Diabetes pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

Bristol-Myers Squibb Company

Baxter International Inc.

F. Hoffmann-La Roche Ltd.


Eli Lilly and Company

Athersys, Inc.

Daiichi Sankyo Company, Ltd

Euroscreen S.A.

Biocon Limited

Yuhan Corporation

Array BioPharma Inc.


Torrent Pharmaceuticals Limited

Choongwae Pharma Corp

Hanall Pharmaceutical Co., Ltd.


Suven Life Sciences Ltd.

Galapagos NV

Proximagen Neuroscience plc.

Transgene Biotek Ltd

Angelini Group

Betagenon AB

Biotecnol SA

Jenrin Discovery, Inc.

Phosphagenics Limited

Xenon Pharmaceuticals Inc.

Spherix Incorporated

Ambrx, Inc.

Five Prime Therapeutics, Inc.

GP Pharm, S.A.

Conatus Pharmaceuticals Inc.

MSM Protein Technologies, Inc.

Zealand Pharma A/S

Indus Biotech Private Limited

Theracos, Inc.

Signum Biosciences, Inc.

PharmaIN Corporation

AUS Bio Limited


Rhythm Pharmaceuticals

For more information visit

Source: Global Markets Direct

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Source: Research and Markets